Australia markets close in 50 minutes

Silo Pharma, Inc. (SILO)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.1902+0.0242 (+14.58%)
At close: 3:50PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 518.77M
Enterprise value 311.63M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)121.92
Price/book (mrq)5.01
Enterprise value/revenue 375.54
Enterprise value/EBITDA 7N/A

Trading information

Stock price history

Beta (5Y monthly) -1.87
52-week change 3-52.57%
S&P500 52-week change 334.63%
52-week high 30.4950
52-week low 30.1320
50-day moving average 30.1712
200-day moving average 30.2364

Share statistics

Avg vol (3-month) 3120.97k
Avg vol (10-day) 3179.03k
Shares outstanding 598.67M
Implied shares outstanding 6N/A
Float 85.59M
% held by insiders 113.26%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 June 2021


Profit margin 0.00%
Operating margin (ttm)-1,914.85%

Management effectiveness

Return on assets (ttm)-47.24%
Return on equity (ttm)-87.05%

Income statement

Revenue (ttm)153.93k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)2,972.40%
Gross profit (ttm)-135.2k
Net income avi to common (ttm)-4.22M
Diluted EPS (ttm)-0.0480
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.75M
Total cash per share (mrq)0.05
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)18.83
Book value per share (mrq)0.04

Cash flow statement

Operating cash flow (ttm)-1.66M
Levered free cash flow (ttm)-455.25k